STOCKTON, CALIFORNIA/February 28, 2013/ Newswire/ — Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the publication of “Reversing Diabetes” on Amazon’s Kindle platform. The book, authored by Dr. Barkat Charania and Dr. Kevin Buckman, is the culmination of 30 years of research and experience with diabetes, including the treatment of over 10,000 patients with the disease. The book can be purchased here: http://www.amazon.com/dp/B00BLTJAS2 .
The book discusses in detail Artificial Pancreas Therapy, the only proven therapy that has been found to treat and reverse many of the complications of diabetes, as well as other methods of treatment.
“Diabetes is an epidemic, and cases are growing at an amazingly high rate”, states Dr. Buckman. “I am happy to release this book in its electronic format, so that people who are afflicted with the disease can have access to the vital information that it provides, and to coincide the release with Viratech’s agreement to develop a social network for the Diabetes.net website”, he added.
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, leveraging the utility of social collaboration, which will allow biotech research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new biotech diagnostics and therapies.
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Kevin Buckman MD
Viratech, Corp.
http://viratech.org
Email Contact: info@viratech.org
209-477-3030